Literature DB >> 2423719

Lyme disease during pregnancy.

L E Markowitz, A C Steere, J L Benach, J D Slade, C V Broome.   

Abstract

Lyme disease is an increasingly recognized tick-borne illness caused by a spirochete, Borrelia burgdorferi. Because the etiologic agent of Lyme disease is a spirochete, there has been concern about the effect of maternal Lyme disease on pregnancy outcome. We reviewed cases of Lyme disease in pregnant women who were identified before knowledge of the pregnancy outcomes. Nineteen cases were identified with onset between 1976 and 1984. Eight of the women were affected during the first trimester, seven during the second trimester, and two during the third trimester; in two, the trimester of onset was unknown. Thirteen received appropriate antibiotic therapy for Lyme disease. Of the 19 pregnancies, five had adverse outcomes, including syndactyly, cortical blindness, intrauterine fetal death, prematurity, and rash in the newborn. Adverse outcomes occurred in cases with infection during each of the trimesters. Although B burgdorferi could not be implicated directly in any of the adverse outcomes, the frequency of such outcomes warrants further surveillance and studies of pregnant women with Lyme disease.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2423719

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


  13 in total

Review 1.  Lyme disease.

Authors:  D W Rahn; S E Malawista
Journal:  West J Med       Date:  1991-06

Review 2.  Ocular Lyme disease: case report and review of the literature.

Authors:  D J Kauffmann; G P Wormser
Journal:  Br J Ophthalmol       Date:  1990-06       Impact factor: 4.638

3.  Immunogenic integral membrane proteins of Borrelia burgdorferi are lipoproteins.

Authors:  M E Brandt; B S Riley; J D Radolf; M V Norgard
Journal:  Infect Immun       Date:  1990-04       Impact factor: 3.441

4.  Fetal outcome in murine Lyme disease.

Authors:  R M Silver; L Yang; R A Daynes; D W Branch; C M Salafia; J J Weis
Journal:  Infect Immun       Date:  1995-01       Impact factor: 3.441

Review 5.  Current recommendations for the treatment of Lyme disease.

Authors:  L H Sigal
Journal:  Drugs       Date:  1992-05       Impact factor: 9.546

6.  Infants born to mothers with antibodies against Borrelia burgdorferi at delivery.

Authors:  D Nadal; U A Hunziker; H U Bucher; W H Hitzig; G Duc
Journal:  Eur J Pediatr       Date:  1989-02       Impact factor: 3.183

Review 7.  Lyme borreliosis: ten years after discovery of the etiologic agent, Borrelia burgdorferi.

Authors:  W Burgdorfer
Journal:  Infection       Date:  1991 Jul-Aug       Impact factor: 3.553

8.  Lyme disease and pregnancy.

Authors:  J M Alexander; S M Cox
Journal:  Infect Dis Obstet Gynecol       Date:  1995

9.  A systematic review on the impact of gestational Lyme disease in humans on the fetus and newborn.

Authors:  Lisa A Waddell; Judy Greig; L Robbin Lindsay; Alison F Hinckley; Nicholas H Ogden
Journal:  PLoS One       Date:  2018-11-12       Impact factor: 3.240

Review 10.  An Overview of Tickborne Infections in Pregnancy and Outcomes in the Newborn: The Need for Prospective Studies.

Authors:  John S Lambert
Journal:  Front Med (Lausanne)       Date:  2020-03-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.